Exendin Derivative 1

Send Inquiry
Exendin Derivative 1
Details
Core structure: GLP-1 receptor agonist derivative modified on the basis of Exendin-4 backbone, optimizing receptor affinity, metabolic stability or tissue targeting through amino acid substitution and terminal modification, retaining GLP-1 receptor agonistic activity, for metabolic disease mechanism research and peptide drug screening
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Metabolic Regulatory Peptide / GLP-1 Receptor Agonist Derivative
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of exendin derivative 1 in China, also supports custom service. Welcome to wholesale bulk high quality exendin derivative 1 from our factory. Contact us for more details.

 

Product name Exendin derivative 1
Description This peptide is a structurally modified derivative of Exendin‑4, retaining the core domain for GLP‑1 receptor binding. It can specifically bind and activate GLP‑1 receptors on the surface of islet β cells, glucose‑dependently promote insulin secretion, inhibit glucagon release, delay gastric emptying, and lower blood glucose. After structural modification, its metabolic stability, receptor affinity or pharmacokinetic properties are optimized compared with native Exendin‑4. It is a customized tool peptide for GLP‑1 drug structure‑activity relationship research and metabolic disease mechanism research.
Peptide purity (HPLC, %) 95%/98%/99%
Theoretical molecular weight (Da) ~4200 (subject to actual modified sequence)
Structure type Exendin‑4 derived modified peptide

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Modification Type Length (aa)
Exendin derivative 1 Exendin derivative 1; Exendin-4 analog GLP-1 receptor agonism, Hypoglycemic metabolic regulation, SAR research, Modified derivative peptide, Diabetes research, Metabolic peptide Exendin-4 homologous backbone with site modifications for optimized activity and stability Large modified peptide, subject to actual sequence - ~4200 (theoretical) Amino acid site substitution / terminal modification ~39

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-EXD001 white powder Store at -20℃, sealed, dry & protected from light, aliquoted; avoid repeated freeze-thaw cycles Stable for 2 weeks at 2-8℃ sealed & dry; ice pack shipping recommended Stable for 7 days at 4℃; stability better than native Exendin-4 after modification**Moderate water solubility, soluble in dilute acetic acid or weakly acidic buffer**. Solubility slightly varies with modification degree Stable for 2 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-EXD001 Structurally modified Exendin-4 derivative that retains GLP-1 receptor agonistic activity with optimized metabolic and receptor properties This derivative performs amino acid substitution, terminal modification or side chain engineering on specific sites of Exendin-4, and on the basis of retaining the core activity of GLP-1 receptor agonism, specifically optimizes certain properties: such as improving receptor binding affinity, enhancing resistance to dipeptidyl peptidase degradation, prolonging in vivo half-life, and improving tissue distribution characteristics. It can glucose-dependently promote insulin secretion, inhibit excessive glucagon release, delay gastric emptying, reduce food intake, and exert metabolic regulatory effects of hypoglycemia and weight loss. It is mainly used for structure-activity relationship research and drug screening of GLP-1 peptides. Type 2 diabetes research, Obesity metabolism research, GLP-1 structure-activity relationship, Peptide drug screening, Islet function research, Metabolic disease mechanism Glucagon-Like Peptide-1 Receptor (GLP-1R); cAMP/PKA signaling pathway; Insulin secretion and glucose metabolism regulatory pathway

Hot Tags: exendin derivative 1, China exendin derivative 1 manufacturers, suppliers, factory, 121062-08-6, 129954-34-3, CAS 129954 34 3, Melanotan I acetate, Retatrutide, Selank

Send Inquiry